source
- Celiac disease faces new therapeutic possibilities as companies target underlying inflammationCeliac disease affects roughly one in every hundred people worldwide, imposing a daily burden that goes far beyond dietary restrictions. Currently, patients have no approved medicines and must rel…
- FDA clears Dexcom's Stelo as first OTC continuous glucose monitor for childrenThe U.S. Food and Drug Administration cleared Dexcom's Stelo Glucose Biosensor System for over-the-counter use in children two years of age and older who do not use insulin. This is the first OTC…